ArticleJournal of pharmacy & bioallied sciences2025
Evaluation of Adipocytokines Level in Newly Diagnosed Hypothyroid Patients.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypothyroidism, a prevalent endocrine disorder, is associated with significant alterations in lipid metabolism and adipocytokine levels, particularly leptin and adiponectin, which may contribute to cardiovascular risk. The interrelation of thyroid hormones and adipocytokines remains inadequately explored. Objective: This study aims to evaluate the levels of leptin and adiponectin in newly diagnosed hypothyroid patients and their potential correlation with thyroid-stimulating hormone (TSH) levels. Materials and Methods: A cross-sectional study was conducted on 60 subjects divided into two groups: 26 newly diagnosed hypothyroid patients (Group A) and 31 healthy controls (Group B). Anthropometric parameters, serum TSH, T3, T4, leptin, and adiponectin levels were measured using standardized ELISA techniques. Statistical analysis was performed using SPSS version 17.0. Results: Adiponectin levels were significantly lower in hypothyroid patients compared to controls, suggesting a potential cardiovascular risk marker. Leptin levels were elevated in hypothyroid patients but did not reach statistical significance. Body mass index (BMI) was comparable across groups, minimizing confounding effects of obesity. Conclusion: This study highlights the significant reduction in adiponectin levels in hypothyroidism, reinforcing its potential role in cardiovascular risk. While leptin levels showed an increasing trend, further research with larger sample sizes is needed to confirm their significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.